Future of Liquid Biopsy from PARADIGM Study to Inform Patient Selection
Time: 11:30 am
day: Conference Day 2
Details:
- Overview of Liquid biopsy (ctDNA testing)
- Utility case of liquid biopsy based on PARADIGM study to describe validated and adequately sensitive plasma ctDNA assay may inform appropriate selection of patients for frontline metastatic colorectal cancer patients
- Limitation and future perspective of liquid biopsy in clinical practice
